IJR News — today's news from every side

IJR News — today's news from every side

blockversewordysbillionaire.aiyourlistWhiteboardAppquizieunschool

Loading

Want your own hosted, self-optimizing clone of this — or any OpenServe site? Open Development for enterprise →

© OpenServe Holdings LLC

Privacy Notice Data rights Terms of Service Feedback Cookie NoticeHelp Acceptable Use Copyright AI Notice Your Privacy Choices Subprocessors Data Processing Addendum Installed App Terms Company Solutions Free assessment Investors Get the app Contact

News

Home
Politics
World
Sports
Markets
Business
Entertainment
Music
Health
Tech
Science
Good News
Encouragement
Video
Meme Wars

Brands

Yourlist
Quizie
FaithTap
Blessed
All brands

New Studies Probe COVID Vaccine Links to Respiratory Illness and Kidney Risks — Experts Urge Caution — Nov 20, 2025Two major studies published this month are raising new questions about potential health risks associated with the COVID-19 vaccine — but researchers and independent experts warn the findings should be interpreted…

China Weaponizes Vape Regulations To Corner US Market — May 20, 2026Chinese products have dominated the U.S. vaping market in recent years, posing major health and national security risks. China has been heavily flooding the U.S. with illicit vape products in recent years. Up to 85% of…

China obesity rate expected above 65% by 2030 — Aug 24, 2026China’s National Health Commission suggests obesity could exceed 65% of the population by 2030, triggering a push by major drugmakers to promote GLP-1 weight-loss injections through indirect public advertising in places like metro stations and stadiums due to bans on direct prescription-drug ads. Companies including Novo Nordisk, Lilly, Pfizer, and Innovent Biologics are vying for market share, with Lilly leading online sales on Alibaba/JD.com and campaigns emphasizing obesity risks and related conditions such as sleep apnea without naming products.

Nestlé Uses AI to Target GLP-1 UsersHealth — Aug 14, 2026The rapid rise of GLP-1 weight‑loss drugs is reshaping the market as Nestlé leverages AI to turn potential threats into opportunities by developing nutrition products and addressing drug side effects, while major pharma players like Lilly and Novo Nordisk navigate revenue trajectories and competitive disputes. Across the industry, executives see GLP-1 therapies expanding beyond weight loss into broader health benefits, with AstraZeneca highlighting broader applications and regulators flagging safety and counterfeit risks as demand climbs.

IJRAmericans Fought To Save South Korea: Are South Koreans Forgetting?James P. Pinkerton · 5 min · 7h